Our original Jan. 29 date had to be cancelled, and we are now on for Thursday, April 2. The program is spelled out below. Because some who had originally signed up cannot attend now, room has opened up. So anyone who would like to attend—please RSVP just as soon as you can!
The New York Genome Center (NYGC) comprises an exceptional global consortium of renowned academic, medical, and industry leaders devoted to translating genomic research into clinical solutions for serious disease. NYGC research is at the forefront of transforming biomedical research and clinical care, with the mission of saving lives.
Located at the nexus of Greenwich Village, SoHo and TriBeCa, the NYGC is a state-of-the-art hub for genome sequencing, analytics, bioinformatics, high-performance computing, and research that opened in July, 2013. This environmentally responsible facility was designed with an emphasis on spatial flexibility and collaboration.
Five of NYGC’s imaginative, productive genome scientists will introduce their complex work with clarity, highlighting its practical relevance to human health and disease:
● Will Liao, PhD, is a computational biologist from SUNY Stony Brook and Cold Spring Harbor who develops technologies for producing data that will expand our understanding of how noncoding regions of the genome impact development and disease biology.
● Nathan Pearson, PhD, is Senior Director of Scientific Engagement and Public Outreach who combines lab, computer, and field work to cast light on how human genetic variation reflects keyaspects of our health and history. He has worked with genome-curious individuals that include historian Henry Louis Gates, Jr and singer Ozzy Osbourne.
● Nico Robine, PhD, oversees RNA sequence analyses; he trained in Paris and Goteborg, and is now at MSKCC. He has discovered dozens of new microRNAs and identified a new class of Piwi interacting RNAs (piRNAs).
● Vlada Vacic, PhD, is a Columbia University computer scientist who focuses on quantitative human genetics, functional genomics, and genetics of neurodegenerative disorders.
● Ana Vasileva, PhD, is a molecular biologist who works in Dr. Tuuli Lappalainen’s research group here and at Columbia University, focusing on various aspects of functional genetic variation in human populations.
Thursday, April 2, 11 am–1pm
11–11:30: registration, networking
11:30: presentations, Q&A, breakout groups
Lunch & beverages provided
Free for 2015 Dues Paid SWINY members*
$10 for nonmembers
$5 for students
(*Become a SWINY member now: www.swiny.org/join-swiny)
101 Avenue of the Americas (6th Ave) just north of Canal Street, where the SoHo, Tribeca, and Hudson Square neighborhoods meet (http://www.nygenome.org/)